RECRUITING

Validation of COMPAT-SF Spanish Translation

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Prospective translation validation pilot study that will collect data from Spanish-speaking CP patients seen at Methodist Dallas Medical Center (MDMC) beginning June 2024 through July 2027, in order to validate a Spanish-translated COMPAT-SF instrument.

Official Title

Validation of COMPAT-SF Spanish Translation

Quick Facts

Study Start:2024-09-13

Study Completion:2026-09-13

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06698302

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* 18 years or older in age * Have a definite CP diagnosis and a stable pain pattern with no new interventions or medications in the last three months * Able to read and understand the study information in Spanish * Personally signed and dated ICF indicating that the subject has been informed of all pertinent aspects of the study * Subject is willing and able to comply with the scheduled questionnaires	* Subjects who do not meet the criteria in section 4.1

Inclusion Criteria

Exclusion Criteria

* 18 years or older in age
* Have a definite CP diagnosis and a stable pain pattern with no new interventions or medications in the last three months
* Able to read and understand the study information in Spanish
* Personally signed and dated ICF indicating that the subject has been informed of all pertinent aspects of the study
* Subject is willing and able to comply with the scheduled questionnaires

* Subjects who do not meet the criteria in section 4.1

Contacts and Locations

Study Contact

Jeff Wilson

CONTACT

2149471279

JeffreyWilson@mhd.com

Study Locations (Sites)

Methodist Dallas Medical Center- Clinical Research Institute

Dallas, Texas, 75203

United States

Collaborators and Investigators

Sponsor: Methodist Health System

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-09-13

Study Completion Date2026-09-13

Study Record Updates

Study Start Date2024-09-13

Study Completion Date2026-09-13

Terms related to this study

Additional Relevant MeSH Terms

Chronic Pancreatitis